A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalation.
| Image |  |
|---|---|
| Description | scientific article published in January 2002 |
| Author/s |
author: Florence Raynaud Penella Woll |
| Publication date | January 1, 2002 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |